Brickwood Asset Management LLP Has $35.92 Million Stock Position in Envista Holdings Corporation (NYSE:NVST)

Brickwood Asset Management LLP boosted its stake in shares of Envista Holdings Corporation (NYSE:NVST) by 0.3% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,080,971 shares of the company’s stock after buying an additional 5,416 shares during the quarter. Envista makes up 27.6% of Brickwood Asset Management LLP’s portfolio, making the stock its largest position. Brickwood Asset Management LLP owned 1.21% of Envista worth $35,918,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Franklin Resources Inc. raised its holdings in shares of Envista by 72.6% in the 4th quarter. Franklin Resources Inc. now owns 6,854,506 shares of the company’s stock valued at $132,223,000 after purchasing an additional 2,882,844 shares in the last quarter. Norges Bank bought a new stake in shares of Envista in the 4th quarter valued at about $38,052,000. Dimensional Fund Advisors LP raised its holdings in shares of Envista by 19.2% in the 4th quarter. Dimensional Fund Advisors LP now owns 6,762,091 shares of the company’s stock valued at $130,440,000 after purchasing an additional 1,089,923 shares in the last quarter. Deerfield Management Company L.P. Series C raised its holdings in shares of Envista by 4,949.9% in the 4th quarter. Deerfield Management Company L.P. Series C now owns 1,018,415 shares of the company’s stock valued at $19,645,000 after purchasing an additional 998,248 shares in the last quarter. Finally, Pzena Investment Management LLC bought a new stake in shares of Envista in the 4th quarter valued at about $16,979,000.

Wall Street Analyst Weigh In

NVST has been the subject of several recent research reports. Morgan Stanley set a $16.00 price target on shares of Envista in a report on Tuesday, April 15th. New Street Research set a $19.00 price objective on shares of Envista in a research note on Thursday, March 6th. Needham & Company LLC reiterated a “hold” rating on shares of Envista in a research note on Thursday, March 6th. Piper Sandler reduced their price objective on shares of Envista from $18.00 to $17.00 and set a “neutral” rating for the company in a research note on Wednesday, April 30th. Finally, Bank of America reduced their price objective on shares of Envista from $26.00 to $23.00 and set a “buy” rating for the company in a research note on Tuesday, April 29th. One research analyst has rated the stock with a sell rating, nine have given a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, Envista has an average rating of “Hold” and a consensus target price of $20.23.

Envista Stock Up 1.4%

NYSE:NVST opened at $18.88 on Friday. The company has a market cap of $3.20 billion, a PE ratio of -2.89, a P/E/G ratio of 1.20 and a beta of 0.99. Envista Holdings Corporation has a twelve month low of $14.22 and a twelve month high of $23.00. The company has a current ratio of 2.12, a quick ratio of 1.82 and a debt-to-equity ratio of 0.43. The company’s 50 day moving average is $17.39 and its two-hundred day moving average is $18.46.

Envista (NYSE:NVST) last released its earnings results on Thursday, May 1st. The company reported $0.24 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.04. The company had revenue of $616.90 million for the quarter, compared to the consensus estimate of $608.17 million. Envista had a negative net margin of 44.90% and a positive return on equity of 4.07%. Envista’s revenue was down 1.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.26 EPS. Analysts anticipate that Envista Holdings Corporation will post 1 EPS for the current year.

Envista Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.